Keros Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lexington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Keros Therapeutics, Inc. has filed 532 SEC EDGAR filings since 29 Apr 2016

SEC filing history

Showing 151-175 of 532 matching filings.

Per page
25
Current page
7
4

4 filing

Filing date
19 Feb 2025
Reporting date
18 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Feb 2025
Reporting date
18 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Feb 2025
Reporting date
18 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-91484

SCHEDULE 13G filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91484

SCHEDULE 13G/A filing

Filing date
07 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
24 Jan 2025
Reporting date
04 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2024
Reporting date
08 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Nov 2024
Reporting date
01 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .